Detalhe da pesquisa
1.
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.
Mol Cancer
; 23(1): 78, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643157
2.
Special Issue "From Basic Science to Treatment Strategies: Personalized Cancer Therapy".
Int J Mol Sci
; 25(3)2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338712
3.
Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across Cancers.
Int J Mol Sci
; 25(1)2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203795
4.
NTRK Therapy among Different Types of Cancers, Review and Future Perspectives.
Int J Mol Sci
; 25(4)2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397049
5.
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.
BMC Cancer
; 23(1): 1000, 2023 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853341
6.
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Oncologist
; 2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536733
7.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
8.
Lung Cancer in the Young.
Lung
; 198(1): 195-200, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31773258
9.
Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America.
Oncology
; 96(4): 207-216, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476928
10.
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.
Biochem Biophys Res Commun
; 500(3): 621-625, 2018 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679564
11.
Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant.
Am J Ther
; 27(6): e640-e642, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796161
12.
Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.
Curr Oncol Rep
; 16(9): 400, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25030654
13.
Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population.
Cancers (Basel)
; 16(6)2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539485
14.
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 8: e2300371, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330261
15.
Diversity and Disparities in Lung Cancer Outcomes Among Minorities.
Cancer J
; 29(6): 323-327, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963366
16.
Importance of ROS1 gene fusions in non-small cell lung cancer.
Cancer Drug Resist
; 6(2): 332-344, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37457125
17.
Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC).
Clin Lung Cancer
; 24(2): 120-129, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585341
18.
Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer.
Front Oncol
; 13: 1108124, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035182
19.
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset.
Transl Oncol
; 36: 101744, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516008
20.
Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer.
Front Oncol
; 13: 1215524, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700839